Strong Growth In Western Europe For Krka

Half-yearly results from Slovenian pharmaceutical firm Krka have highlighted strong performance in the company's Western Europe and Overseas (which includes any markets outside of Europe) markets, increasing by EUR33.6mn (US$49.0mn) year-on-year (y-o-y). This, along with positive results from all of the company's regions, helped boost overall company sales by 20% to EUR469.3mn

To read the full article, please take a trial.